Valuation: MediPal Holdings Corporation

Capitalization 55TCr 341.35Cr 295.61Cr 271.24Cr 255.19Cr 475.3Cr 33TCr 482.74Cr 3.22TCr 1.25TCr 16TCr 1.28TCr 1.25TCr P/E ratio 2026
14.2x
P/E ratio 2027 * 13.5x
Enterprise value 55TCr 341.35Cr 295.61Cr 271.24Cr 255.19Cr 475.3Cr 33TCr 482.74Cr 3.22TCr 1.25TCr 16TCr 1.28TCr 1.25TCr EV / Sales 2026
0.16x
EV / Sales 2027 * 0.14x
Free-Float
86.23%
Yield 2026
2.25%
Yield 2027 * 2.54%
14/05 MediPal Holdings Corporation Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2027 CI
14/05 Medipal Holdings Corporation Provides Second Quarter Dividend Guidance for the Year Ending March 31, 2027 CI
14/05 Medipal Holdings Corporation Provides Year-End Dividend Guidance for the Year Ending March 31, 2027 CI
14/05 MediPal Holdings Corporation Declares Dividend for the Year-End Period of the Fiscal Year Ended March 31, 2026, Payable on June 2, 2026 CI
12/05 MediPal Holdings Corporation proposed to acquire remaining 47.60% stake in Paltac Corporation from State Street Bank & Trust Company 505103, JP Morgan Chase Bank 385632, State Street Bank & Trust Company 505001 Obayashi Group, BNYM AS Agt CLTS 10 Percent, BBH For Fidelity Low-Priced STOCK Fund and NORTHERN TRUST CO. RE FIDELITY FUNDS for approximately ¥190 billion. CI
12/05 Japanese Shares Rise as US, Japan Reaffirm FX Coordination MT
12/05 Medipal Launches Tender Offer for Paltac MT
11/05 Paltac to End Treasury Share Buyback Ahead of Medipal Tender Offer MT
09/02 MediPal Holdings Corporation Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2026 CI
09/02 MediPal Holdings Corporation Reports Earnings Results for the Nine Months Ended December 31, 2025 CI
03/02 Nippon Life Insurance Company completed the acquisition of 52.34% stake in Medical Data Vision Co., Ltd. from MediPal Holdings Corporation, Hiroyuki Iwasaki and others for ¥33.9 billion. CI
31/12 Metagen Therapeutics, Inc. announced that it has received ¥3.52 billion in funding from a group of investors CI
15/12 Nippon Life Insurance Company proposed to acquire 62.19% stake in Medical Data Vision Co., Ltd. from MediPal Holdings Corporation, Hiroyuki Iwasaki and others for ¥40.4 billion. CI
1 day+1.06%
1 week-2.71%
Current month-2.71%
1 month-5.06%
3 months-9.01%
6 months+0.79%
Current year-3.52%
1 week 2,620.5
Extreme 2620.5
2,708
1 month 2,620.5
Extreme 2620.5
2,924
Current year 2,620.5
Extreme 2620.5
3,070
1 year 2,294
Extreme 2294
3,070
3 years 2,156
Extreme 2156
3,070
5 years 1,603
Extreme 1603
3,070
10 years 1,426
Extreme 1426
3,070
Manager TitleAgeSince
President 74 01/04/2012
Chief Administrative Officer 73 01/06/2013
Corporate Officer/Principal 68 01/06/2025
Director TitleAgeSince
Director/Board Member 74 01/06/2008
Director/Board Member 63 01/06/2010
Director/Board Member 71 01/06/2007
Change 5d. change 1-year change 3-years change Capi.($)
+1.06%-2.71%+16.52%+16.55% 341.35Cr
+2.47%+4.47%+8.81%+99.42% 9.32TCr
+1.97%+4.53%+32.96%+143.91% 4.82TCr
+0.34%-0.68%-6.41%+276.77% 2.37TCr
+0.99%-1.33%-11.87%-29.49% 805Cr
+2.08%-2.07%-34.03%-29.43% 735.76Cr
+0.35%+1.71%-7.87%-34.81% 685.46Cr
+1.36%+3.18%+16.67%+18.83% 663.57Cr
+0.96%+0.90%-2.21%+16.00% 527.33Cr
+0.40%+3.54%-7.10%-18.20% 365.84Cr
Average +1.20%+0.13%+0.55%+45.96% 2.06TCr
Weighted average by Cap. +1.83%+0.18%+9.62%+107.95%

Financials

2026 2027 *
Net sales 3,79900Cr 2.37TCr 2.05TCr 1.88TCr 1.77TCr 3.3TCr 2,25900Cr 3.35TCr 22TCr 8.71TCr 1,09300Cr 8.9TCr 8.71TCr 3,92000Cr 2.45TCr 2.12TCr 1.94TCr 1.83TCr 3.41TCr 2,33100Cr 3.46TCr 23TCr 8.99TCr 1,12700Cr 9.18TCr 8.98TCr
Net income 4.13TCr 26Cr 22Cr 20Cr 19Cr 36Cr 2.46TCr 36Cr 243.62Cr 95Cr 1.19TCr 97Cr 95Cr 4.02TCr 25Cr 22Cr 20Cr 19Cr 35Cr 2.39TCr 35Cr 237.09Cr 92Cr 1.16TCr 94Cr 92Cr
Net Debt - -
Logo MediPal Holdings Corporation
Medipal Holdings Corp is a Japan-based company principally engaged in the wholesale of pharmaceuticals, cosmetics, daily necessities, and veterinary medicines. The Company operates in three segments. The Prescription Pharmaceuticals Wholesale Business segment engages in wholesale business targeting customers such as hospitals, clinics, and dispensing pharmacies. The Cosmetics, Daily Necessities, and General Pharmaceuticals Wholesale Business segment engages in wholesale business targeting customers such as drugstores, home improvement centers, convenience stores, and supermarkets. The Veterinary Medicines and Food Processing Raw Materials Wholesale Business segment engages in wholesale business targeting customers such as veterinary hospitals, livestock and fisheries producers, and processed food manufacturers. The Company also engages in preventive medicine, research and development of cutting-edge medical technology, non-life insurance agency services, and others.
Employees
13,061
Date Price Change Volume
05/26/05 2,672.50 ¥ +1.06% 3,20,200
04/26/04 2,644.50 ¥ -0.99% 3,88,300
03/26/03 2,671.00 ¥ +0.64% 3,05,300
02/26/02 2,654.00 ¥ -0.51% 3,58,600
01/26/01 2,667.50 ¥ -2.89% 4,99,100
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
4
Last Close Price
2,672.50JPY
Average target price
2,912.50JPY
Spread / Average Target
+8.98%

Quarterly revenue - Rate of surprise